Technology-Supported Treatment of Sleep Apnea in Prediabetes
Launched by UNIVERSITY OF CHICAGO · Jan 8, 2020
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the impact of a treatment called CPAP (continuous positive air pressure) on people who have sleep apnea and are at risk for diabetes due to prediabetes and being overweight or obese. The goal is to see if using CPAP, in addition to making lifestyle changes like eating healthier and exercising, can help improve heart health and reduce the risk of diabetes more effectively than lifestyle changes alone.
To be eligible for this study, participants need to be overweight or obese, have prediabetes, and also have sleep apnea. Unfortunately, those who already have diabetes, are in a formal weight loss program, or have other serious health conditions may not qualify. If you decide to participate, you can expect to receive support for both the lifestyle changes and the CPAP treatment, helping to improve your overall health. This trial is currently recruiting participants of all genders aged 18 and older, so it’s a great opportunity for individuals looking to manage their health proactively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Overweight or obese
- • Prediabetes
- • Sleep apnea
- Exclusion Criteria:
- • Diabetic
- • enrolled in a formal weight loss program
- • Any underlying disease likely to limit life span and/or increase risk of interventions
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Esra Tasali, MD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials